These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 22169052

  • 1. Estradiol valerate/dienogest: a novel combined oral contraceptive.
    Borgelt LM, Martell CW.
    Clin Ther; 2012 Jan; 34(1):37-55. PubMed ID: 22169052
    [Abstract] [Full Text] [Related]

  • 2. Estradiol valerate/dienogest: a novel oral contraceptive.
    Whalen KL, Rose R.
    Ann Pharmacother; 2011 Oct; 45(10):1256-61. PubMed ID: 21917554
    [Abstract] [Full Text] [Related]

  • 3. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
    Ahrendt HJ, Makalová D, Parke S, Mellinger U, Mansour D.
    Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies.
    Endrikat J, Parke S, Trummer D, Schmidt W, Duijkers I, Klipping C.
    Contraception; 2008 Sep; 78(3):218-25. PubMed ID: 18692612
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest.
    Fraser IS, Jensen J, Schaefers M, Mellinger U, Parke S, Serrani M.
    Contraception; 2012 Aug; 86(2):96-101. PubMed ID: 22240178
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of a combined oral contraceptive containing estradiol valerate/dienogest: results from a clinical study conducted in North America.
    Nelson A, Parke S, Mellinger U, Zampaglione E, Schmidt A.
    J Womens Health (Larchmt); 2014 Mar; 23(3):204-10. PubMed ID: 24279594
    [Abstract] [Full Text] [Related]

  • 12. Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment.
    von Schoultz B.
    Climacteric; 2003 Aug; 6 Suppl 2():24-32. PubMed ID: 14669841
    [Abstract] [Full Text] [Related]

  • 13. Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism.
    De Leo V, Fruzzetti F, Musacchio MC, Scolaro V, Di Sabatino A, Morgante G.
    Contraception; 2013 Sep; 88(3):364-8. PubMed ID: 23769016
    [Abstract] [Full Text] [Related]

  • 14. Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study.
    Macìas G, Merki-Feld GS, Parke S, Mellinger U, Serrani M.
    J Obstet Gynaecol; 2013 Aug; 33(6):591-6. PubMed ID: 23919857
    [Abstract] [Full Text] [Related]

  • 15. Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest.
    Saletu B.
    Climacteric; 2003 Aug; 6 Suppl 2():37-45. PubMed ID: 14669843
    [Abstract] [Full Text] [Related]

  • 16. Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life.
    Caruso S, Agnello C, Romano M, Cianci S, Lo Presti L, Malandrino C, Cianci A.
    J Sex Med; 2011 Oct; 8(10):2841-50. PubMed ID: 21810188
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness analysis in the treatment of heavy menstrual bleeding in Spain.
    Calaf J, Lete I, Canals I, Crespo C, Espinós B, Cristóbal I.
    Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():24-31. PubMed ID: 25462215
    [Abstract] [Full Text] [Related]

  • 18. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.
    Raps M, Rosendaal F, Ballieux B, Rosing J, Thomassen S, Helmerhorst F, van Vliet H.
    J Thromb Haemost; 2013 May; 11(5):855-61. PubMed ID: 23410231
    [Abstract] [Full Text] [Related]

  • 19. Contraception containing estradiol valerate and dienogest--advantages, adherence and user satisfaction.
    Graziottin A.
    Minerva Ginecol; 2014 Oct; 66(5):479-95. PubMed ID: 25245997
    [Abstract] [Full Text] [Related]

  • 20. [Association of E2v/DNG as contraceptive choice for a better quality of life of women].
    Nappi RE.
    Minerva Ginecol; 2012 Feb; 64(1):41-52. PubMed ID: 22334230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.